Earnings Call · Q3 FY2021·2021-11-03

Q3 21EPS -13.79%·Rev n/aQ2 21EPS +4.00%·Rev n/aQ1 21EPS -33.33%·Rev n/aQ4 20EPS -36.00%·Rev n/a⚠ consensus missing

BIOCRYST PHARMACEUTICALS INC BCRX

John Bluth — Conference Call Host

Jon Stonehouse — Chief Executive Officer

Charlie Gayer — Chief Commercial Officer

Helen Thackray — Senior Clinical or Medical Affairs Executive

Bill Sheridan — Head of Clinical Development or similar senior clinical role

Anthony Doyle — Chief Financial Officer

−18.1%1d on move date−18.7% vs SPY3d−18.0%5d−14.5%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCRX calls or request research access.

More BCRX calls Browse calls Request research access